A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -46.14% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -40.76%. Over the past 30 days, the price of TNDM has fallen by 3.58%. And in the last five days, it has surged by 9.79%.
Tandem Diabetes Care Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $53.69 on 05/31/24, while the lowest value for the same period was recorded at $15.75 on 04/07/25.
52-week price history of TNDM Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Tandem Diabetes Care Inc’s current trading price is -63.87% away from its 52-week high, while its distance from the 52-week low is 23.16%. The stock’s price range during this period has varied between$15.75 and $53.69. The Tandem Diabetes Care Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.86 million for the day, a figure considerably higher than their average daily volume of 1.71 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Tandem Diabetes Care Inc (TNDM) has experienced a quarterly decline of -47.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.29B and boasts a workforce of 2650 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 27.56, with a change in price of -12.86. Similarly, Tandem Diabetes Care Inc recorded 1,478,553 in trading volume during the last 100 days, posting a change of -39.84%.
TNDM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TNDM stands at 1.80. Similarly, the long-term debt-to-equity ratio is also 1.58.
TNDM Stock Stochastic Average
Tandem Diabetes Care Inc’s raw stochastic average for the past 50 days is presently 18.95%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 91.07%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 50.56% and 43.50%, respectively.
